05 Aug Understanding the FDA’s Role in a Digital Pharma Supply Chain

So, what exactly is a “digital supply chain”?

Picture this: instead of stacks of paper and old-school fax machines, you’ve got barcodes, scanners, cloud-based ERPs, and real-time data flowing seamlessly between partners. Every pallet, case, and bottle has its unique digital fingerprint, and each time it changes hands, that event gets logged in a shareable EPCIS (Electronic Product Code Information Services) file. That’s the essence of a digital supply chain.

At the heart of this shift is a commitment to one thing: patient safety. And that’s where the FDA comes in.

The FDA’s most significant contribution to the digital pharma supply chain is the Drug Supply Chain Security Act (DSCSA). Signed into law in 2013, the DSCSA lays the foundation for a fully electronic, interoperable system to trace prescription drugs through the U.S. supply chain.

Here’s what the DSCSA mandates and how it supports digital transformation:

●      Serialization – each package of prescription drugs must carry a unique identifier, a digital code that makes every product traceable at the unit level.

●      Product Tracing – trading partners (manufacturers, wholesalers, dispensers) must provide and maintain detailed transaction data. This includes Transaction Information (TI), Transaction History (TH), and Transaction Statement (TS). As of November 2024, TH is being phased out in favor of EPCIS-based data exchange.

●      Verification – the FDA requires all trading partners to verify products at risk of being illegitimate, using serial number data to confirm authenticity.

●      Authorized Trading Partners (ATPs) – only verified, authorized entities can participate in the U.S. drug supply chain. The FDA sets the criteria for these designations.

To meet these regulatory requirements, pharma companies are turning to digital infrastructure, including ERP platforms, integrated serialization systems, and EPCIS-based data exchange. The FDA doesn’t just permit this transformation, it demands it.

While the agency doesn’t build the technology, the FDA plays a critical role in defining the standards, timelines, and enforcement practices. It collaborates with solution providers, industry groups (like HDA), and traceability experts to ensure that digital systems align with public health goals.

In essence, the FDA is acting as a digital catalyst, enforcing compliance, but also guiding innovation.

As we approach full DSCSA implementation, pharmaceutical companies need to ensure they are not only compliant but also digitally equipped. With the right systems in place, from serialization-ready ERP software to EPCIS integration, companies can turn FDA mandates into a competitive advantage.

Need help digitizing your supply chain for DSCSA compliance?

Talk to us at DOit. We help pharmaceutical companies streamline operations and stay compliant with a fully integrated, cloud-based ERP system built for the future of pharma.